Literature DB >> 10860777

Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart.

R A Fenton1, E W Dickson, T E Meyer, J G Dobson.   

Abstract

Multiple brief periods of ischemia in the mammalian heart elicits protection against morphologic and functional damage caused by longer-duration ischemia. Preconditioning-induced protection against post-ischemic contractile dysfunction has been reported to be depressed with aging of the adult heart. This study was undertaken to determine whether aging of the adult myocardium reduces the preconditioning-induced attenuation of necrosis observed with ischemia. Isolated, perfused hearts obtained from Fischer 344 rats of either 3 (young) or 22 (aged) months of age were paced and instrumented for determination of developed left ventricular pressure. Necrosis was determined with triphenyltetrazolium. In the absence of preconditioning, young and aged adult hearts made globally ischemic for 45 min developed necrosis involving 53+/-6% and 49+/-6% of the myocardium, respectively. Contractile function (+dP/dt(max)) at 90 min of reperfusion was depressed by 80% in young and 52% in aged hearts, compared to values obtained prior to preconditioning. Preconditioning with two 5 min ischemia/5 min reperfusion cycles significantly reduced necrosis development and enhanced reperfusion contractile function in young hearts. However, in aged adult hearts, the preconditioning did not significantly reduce the development of necrosis or enhance reperfusion contractile function. These data suggest that aging reduces the effectiveness of preconditioning in providing cardioprotection against ischemic-induced myocardial necrosis. Copyright 2000 Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10860777     DOI: 10.1006/jmcc.2000.1189

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  29 in total

Review 1.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Reduced adenosine release from the aged mammalian heart.

Authors:  Richard A Fenton; James G Dobson
Journal:  J Cell Physiol       Date:  2012-11       Impact factor: 6.384

Review 3.  Preconditioning: a paradigm shift in the biology of myocardial ischemia.

Authors:  Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-08       Impact factor: 4.733

Review 4.  The late phase of preconditioning and its natural clinical application--gene therapy.

Authors:  Roberto Bolli; Qian-Hong Li; Xian-Liang Tang; Yiru Guo; Yu-Ting Xuan; Gregg Rokosh; Buddhadeb Dawn
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

Review 5.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

6.  Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats.

Authors:  Nelson Escobales; Rebeca E Nuñez; Sehwan Jang; Rebecca Parodi-Rullan; Sylvette Ayala-Peña; Joshua R Sacher; Erin M Skoda; Peter Wipf; Walter Frontera; Sabzali Javadov
Journal:  J Mol Cell Cardiol       Date:  2014-10-23       Impact factor: 5.000

Review 7.  Ischaemic conditioning: pitfalls on the path to clinical translation.

Authors:  Karin Przyklenk
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 8.  Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency.

Authors:  Donna H Korzick; Timothy S Lancaster
Journal:  Pflugers Arch       Date:  2013-03-23       Impact factor: 3.657

9.  KATP channel blocker does not abolish the protective effect of Na+/H+ exchange 1 inhibition against ischaemia/reperfusion in aged myocardium.

Authors:  Hong Liu; Peter G Moore
Journal:  Eur J Anaesthesiol       Date:  2010-08       Impact factor: 4.330

Review 10.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.